BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11684751)

  • 1. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals.
    Owen RR; Feng W; Thrush CR; Hudson TJ; Austen MA
    Psychiatr Serv; 2001 Nov; 52(11):1523-5. PubMed ID: 11684751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2002 Sep; 159(9):1534-40. PubMed ID: 12202274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
    Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
    Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National prescribing patterns in the management of extrapyramidal symptoms among patients with schizophrenia.
    Luo RD; Belleti DA; Tran D; Arcona S; Salen PN
    Int J Psychiatry Med; 2002; 32(3):261-9. PubMed ID: 12489701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.
    Leslie DL; Rosenheck RA
    J Ment Health Policy Econ; 2003 Sep; 6(3):113-21. PubMed ID: 14646004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in antipsychotics prescribed to veterans with serious mental illness.
    Schwartz E; Charlotte M; Slade E; Medoff D; Li L; Dixon L; Kilbourne A; Kreyenbuhl J
    Gen Hosp Psychiatry; 2015; 37(4):347-51. PubMed ID: 25936673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance between psychotropic prescribing for veterans with PTSD and clinical practice guidelines.
    Jain S; Greenbaum MA; Rosen C
    Psychiatr Serv; 2012 Feb; 63(2):154-60. PubMed ID: 22302333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic Medication Prescriptions for Homeless and Unstably Housed Veterans in the Veterans Affairs Health Care System.
    Tsai J; Szymkowiak D; Radhakrishnan R
    J Clin Psychiatry; 2020 Dec; 82(1):. PubMed ID: 33296148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.
    Leslie DL; Mohamed S; Rosenheck RA
    Psychiatr Serv; 2009 Sep; 60(9):1175-81. PubMed ID: 19723731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing behavior and marketing practices.
    Stone AM
    Psychiatr Serv; 2006 Mar; 57(3):419; author reply 419. PubMed ID: 16525009
    [No Abstract]   [Full Text] [Related]  

  • 11. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
    Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
    Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.
    Patrick V; Schleifer SJ; Nurenberg JR; Gill KJ
    Psychiatr Serv; 2006 Jan; 57(1):21-3. PubMed ID: 16399958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
    Abrams TE; Lund BC; Bernardy NC; Friedman MJ
    Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system.
    Valenstein M; McCarthy JF; Ignacio RV; Dalack GW; Stavenger T; Blow FC
    Psychiatr Serv; 2006 Jan; 57(1):70-6. PubMed ID: 16399965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006.
    Sernyak MJ; Rosenheck RA
    Psychiatr Serv; 2008 May; 59(5):567-9. PubMed ID: 18451019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical decision making in antipsychotic drug choice for schizophrenia.
    Hamann J; Langer B; Leucht S; Busch R; Kissling W
    Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing VA information technology to develop psychiatric resident prescription profiles.
    Rohrbaugh R; Federman DG; Borysiuk L; Sernyak M
    Acad Psychiatry; 2009; 33(1):27-30. PubMed ID: 19349439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors in second-generation antipsychotic switching patterns in a national sample of older veterans with schizophrenia.
    Dassori AM; Copeland LA; Zeber JE; Miller AL
    Psychiatr Serv; 2011 Jan; 62(1):47-53. PubMed ID: 21209299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.